questionsmedicales.fr
Composés hétérocycliques
Composés hétérocycliques à cycles fusionnés
Composés hétérobicycliques
Benzopyranes
Coumarines
4-Hydroxycoumarines
4-Hydroxycoumarines : Questions médicales fréquentes
Termes MeSH sélectionnés :
Early Detection of Cancer
Diagnostic
5
Temps de prothrombine
INR
Symptômes
5
Effets secondaires
Nausées
Réaction allergique
Éruption cutanée
Prévention
5
Précautions
Anticoagulants
Éducation des patients
Anticoagulants
Interactions médicamenteuses
Consultation
Traitements
5
Interactions médicamenteuses
Anticoagulants
Anticoagulants
Alternatives
Complications
5
Facteurs de risque
Anticoagulants
Facteurs de risque
5
Facteurs de risque
Thrombose
Antécédents médicaux
Coagulation
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "4-Hydroxycoumarines : Questions médicales les plus fréquentes",
"headline": "4-Hydroxycoumarines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les 4-Hydroxycoumarines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-10",
"dateModified": "2025-04-04",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "4-Hydroxycoumarines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Coumarines",
"url": "https://questionsmedicales.fr/mesh/D003374",
"about": {
"@type": "MedicalCondition",
"name": "Coumarines",
"code": {
"@type": "MedicalCode",
"code": "D003374",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.150.446"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Acénocoumarol",
"alternateName": "Acenocoumarol",
"url": "https://questionsmedicales.fr/mesh/D000074",
"about": {
"@type": "MedicalCondition",
"name": "Acénocoumarol",
"code": {
"@type": "MedicalCode",
"code": "D000074",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.150.446.520.079"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dicoumarol",
"alternateName": "Dicumarol",
"url": "https://questionsmedicales.fr/mesh/D001728",
"about": {
"@type": "MedicalCondition",
"name": "Dicoumarol",
"code": {
"@type": "MedicalCode",
"code": "D001728",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.150.446.520.203"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Biscoumacétate d'éthyle",
"alternateName": "Ethyl Biscoumacetate",
"url": "https://questionsmedicales.fr/mesh/D005017",
"about": {
"@type": "MedicalCondition",
"name": "Biscoumacétate d'éthyle",
"code": {
"@type": "MedicalCode",
"code": "D005017",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.150.446.520.451"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Phenprocoumone",
"alternateName": "Phenprocoumon",
"url": "https://questionsmedicales.fr/mesh/D010644",
"about": {
"@type": "MedicalCondition",
"name": "Phenprocoumone",
"code": {
"@type": "MedicalCode",
"code": "D010644",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.150.446.520.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Warfarine",
"alternateName": "Warfarin",
"url": "https://questionsmedicales.fr/mesh/D014859",
"about": {
"@type": "MedicalCondition",
"name": "Warfarine",
"code": {
"@type": "MedicalCode",
"code": "D014859",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.150.446.520.914"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "4-Hydroxycoumarines",
"alternateName": "4-Hydroxycoumarins",
"code": {
"@type": "MedicalCode",
"code": "D015110",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Li Sheng",
"url": "https://questionsmedicales.fr/author/Li%20Sheng",
"affiliation": {
"@type": "Organization",
"name": "Department of Drug Metabolism, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China."
}
},
{
"@type": "Person",
"name": "Zahra Hosseini-Khah",
"url": "https://questionsmedicales.fr/author/Zahra%20Hosseini-Khah",
"affiliation": {
"@type": "Organization",
"name": "Diabetes Research Center, Mazandaran University of Medical Sciences, Sari, Iran."
}
},
{
"@type": "Person",
"name": "Saeed Emami",
"url": "https://questionsmedicales.fr/author/Saeed%20Emami",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicinal Chemistry and Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran. sdemami12@gmail.com."
}
},
{
"@type": "Person",
"name": "Jhonnathan Brawley",
"url": "https://questionsmedicales.fr/author/Jhonnathan%20Brawley",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Nevada, Reno, Nevada 89557-0216, United States."
}
},
{
"@type": "Person",
"name": "Amarawan Intasiri",
"url": "https://questionsmedicales.fr/author/Amarawan%20Intasiri",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Nevada, Reno, Nevada 89557-0216, United States."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Early Detection of Ovarian Cancer.",
"datePublished": "2023-11-01",
"url": "https://questionsmedicales.fr/article/37604591",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1101/cshperspect.a041337"
}
},
{
"@type": "ScholarlyArticle",
"name": "Early Detection of Pancreatic Cancer.",
"datePublished": "2023-04-25",
"url": "https://questionsmedicales.fr/article/37166325",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000530790"
}
},
{
"@type": "ScholarlyArticle",
"name": "Early detection of lung cancer",
"datePublished": "2022-06-09",
"url": "https://questionsmedicales.fr/article/35612288",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1039/d1nr07670a"
}
},
{
"@type": "ScholarlyArticle",
"name": "Nanobodies for the Early Detection of Ovarian Cancer.",
"datePublished": "2022-11-08",
"url": "https://questionsmedicales.fr/article/36430166",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms232213687"
}
},
{
"@type": "ScholarlyArticle",
"name": "Biomarkers for Early Detection of Cancer: Molecular Aspects.",
"datePublished": "2023-03-09",
"url": "https://questionsmedicales.fr/article/36982344",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24065272"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétérocycliques à cycles fusionnés",
"item": "https://questionsmedicales.fr/mesh/D000072471"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés hétérobicycliques",
"item": "https://questionsmedicales.fr/mesh/D006574"
},
{
"@type": "ListItem",
"position": 5,
"name": "Benzopyranes",
"item": "https://questionsmedicales.fr/mesh/D001578"
},
{
"@type": "ListItem",
"position": 6,
"name": "Coumarines",
"item": "https://questionsmedicales.fr/mesh/D003374"
},
{
"@type": "ListItem",
"position": 7,
"name": "4-Hydroxycoumarines",
"item": "https://questionsmedicales.fr/mesh/D015110"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : 4-Hydroxycoumarines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur 4-Hydroxycoumarines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur 4-Hydroxycoumarines",
"description": "Comment diagnostiquer une surdose de 4-hydroxycoumarines ?\nQuels tests sont utilisés pour surveiller le traitement par 4-hydroxycoumarines ?\nQuels symptômes indiquent une complication du traitement ?\nComment évaluer l'efficacité des 4-hydroxycoumarines ?\nQuels signes cliniques nécessitent une évaluation urgente ?",
"url": "https://questionsmedicales.fr/mesh/D015110?mesh_terms=Early+Detection+of+Cancer#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur 4-Hydroxycoumarines",
"description": "Quels sont les effets secondaires courants des 4-hydroxycoumarines ?\nComment reconnaître une réaction allergique aux 4-hydroxycoumarines ?\nQuels symptômes peuvent indiquer une thrombose malgré le traitement ?\nQuels signes indiquent une surdose de 4-hydroxycoumarines ?\nQuels symptômes nécessitent un ajustement de la dose ?",
"url": "https://questionsmedicales.fr/mesh/D015110?mesh_terms=Early+Detection+of+Cancer#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur 4-Hydroxycoumarines",
"description": "Comment prévenir les complications des 4-hydroxycoumarines ?\nQuelles précautions prendre lors de l'utilisation de 4-hydroxycoumarines ?\nComment éduquer les patients sur les 4-hydroxycoumarines ?\nQuels aliments éviter avec les 4-hydroxycoumarines ?\nComment gérer les interactions médicamenteuses ?",
"url": "https://questionsmedicales.fr/mesh/D015110?mesh_terms=Early+Detection+of+Cancer#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur 4-Hydroxycoumarines",
"description": "Comment traiter une surdose de 4-hydroxycoumarines ?\nQuels médicaments interagissent avec les 4-hydroxycoumarines ?\nQuelle est l'alternative aux 4-hydroxycoumarines ?\nComment ajuster la dose de 4-hydroxycoumarines ?\nQuels sont les traitements de soutien lors d'une surdose ?",
"url": "https://questionsmedicales.fr/mesh/D015110?mesh_terms=Early+Detection+of+Cancer#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur 4-Hydroxycoumarines",
"description": "Quelles sont les complications possibles des 4-hydroxycoumarines ?\nComment gérer une hémorragie due aux 4-hydroxycoumarines ?\nQuels facteurs augmentent le risque de complications ?\nComment prévenir les thromboses sous traitement ?\nQuels signes indiquent une complication grave ?",
"url": "https://questionsmedicales.fr/mesh/D015110?mesh_terms=Early+Detection+of+Cancer#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur 4-Hydroxycoumarines",
"description": "Quels sont les facteurs de risque pour les complications des 4-hydroxycoumarines ?\nComment l'alimentation influence-t-elle l'efficacité des 4-hydroxycoumarines ?\nQuels médicaments augmentent le risque de saignement ?\nComment l'âge affecte-t-il le traitement par 4-hydroxycoumarines ?\nQuels antécédents médicaux sont préoccupants ?",
"url": "https://questionsmedicales.fr/mesh/D015110?mesh_terms=Early+Detection+of+Cancer#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une surdose de 4-hydroxycoumarines ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests de coagulation et l'évaluation des symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour surveiller le traitement par 4-hydroxycoumarines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le temps de prothrombine (TP) et l'INR sont les tests principaux pour surveiller l'efficacité."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une complication du traitement ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des saignements inhabituels, des ecchymoses ou des douleurs abdominales peuvent indiquer une complication."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité des 4-hydroxycoumarines ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par la réduction des événements thromboemboliques et les résultats des tests de coagulation."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques nécessitent une évaluation urgente ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes de saignement grave, comme des hémorragies cérébrales ou gastro-intestinales, nécessitent une évaluation urgente."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires courants des 4-hydroxycoumarines ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent des saignements, des nausées et des douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une réaction allergique aux 4-hydroxycoumarines ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées, des démangeaisons ou un gonflement peuvent indiquer une réaction allergique."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une thrombose malgré le traitement ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs, un gonflement ou une rougeur dans une jambe peuvent indiquer une thrombose persistante."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une surdose de 4-hydroxycoumarines ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des saignements excessifs, des ecchymoses et des douleurs abdominales peuvent indiquer une surdose."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent un ajustement de la dose ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des saignements fréquents ou des résultats d'INR élevés peuvent nécessiter un ajustement de la dose."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications des 4-hydroxycoumarines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surveillance régulière de l'INR et une éducation des patients sont essentielles pour prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quelles précautions prendre lors de l'utilisation de 4-hydroxycoumarines ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les activités à risque de blessure et informer les professionnels de santé de l'utilisation."
}
},
{
"@type": "Question",
"name": "Comment éduquer les patients sur les 4-hydroxycoumarines ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Informer sur les effets secondaires, l'importance des tests de coagulation et les signes d'alerte."
}
},
{
"@type": "Question",
"name": "Quels aliments éviter avec les 4-hydroxycoumarines ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les aliments riches en vitamine K, comme les légumes à feuilles vertes, pour maintenir l'efficacité."
}
},
{
"@type": "Question",
"name": "Comment gérer les interactions médicamenteuses ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consulter un professionnel de santé avant de prendre d'autres médicaments pour éviter les interactions."
}
},
{
"@type": "Question",
"name": "Comment traiter une surdose de 4-hydroxycoumarines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut l'administration de vitamine K et la surveillance des paramètres de coagulation."
}
},
{
"@type": "Question",
"name": "Quels médicaments interagissent avec les 4-hydroxycoumarines ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antibiotiques, des anti-inflammatoires et certains antifongiques peuvent interagir avec ces anticoagulants."
}
},
{
"@type": "Question",
"name": "Quelle est l'alternative aux 4-hydroxycoumarines ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anticoagulants directs comme le rivaroxaban ou l'apixaban sont des alternatives possibles."
}
},
{
"@type": "Question",
"name": "Comment ajuster la dose de 4-hydroxycoumarines ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La dose est ajustée en fonction des résultats de l'INR et des facteurs de risque individuels."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements de soutien lors d'une surdose ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des transfusions de plaquettes et des soins intensifs peuvent être nécessaires en cas de surdose sévère."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles des 4-hydroxycoumarines ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des hémorragies, des thromboses et des réactions allergiques."
}
},
{
"@type": "Question",
"name": "Comment gérer une hémorragie due aux 4-hydroxycoumarines ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut l'arrêt du médicament, l'administration de vitamine K et des soins médicaux appropriés."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, les maladies hépatiques et l'utilisation concomitante d'autres anticoagulants augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment prévenir les thromboses sous traitement ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un suivi régulier et ajuster la dose en fonction des résultats de l'INR pour prévenir les thromboses."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une complication grave ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs thoraciques, des difficultés respiratoires ou des saignements importants indiquent une complication grave."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les complications des 4-hydroxycoumarines ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents de thrombose, l'âge avancé et les maladies hépatiques sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "Comment l'alimentation influence-t-elle l'efficacité des 4-hydroxycoumarines ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en vitamine K peut réduire l'efficacité des 4-hydroxycoumarines."
}
},
{
"@type": "Question",
"name": "Quels médicaments augmentent le risque de saignement ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anti-inflammatoires non stéroïdiens (AINS) et certains antibiotiques peuvent augmenter le risque de saignement."
}
},
{
"@type": "Question",
"name": "Comment l'âge affecte-t-il le traitement par 4-hydroxycoumarines ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées peuvent avoir une sensibilité accrue et nécessiter un ajustement de la dose."
}
},
{
"@type": "Question",
"name": "Quels antécédents médicaux sont préoccupants ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antécédents de maladies hépatiques ou de troubles de la coagulation sont préoccupants lors du traitement."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 04/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Drug Metabolism, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.
Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD Study, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Diabetes Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Department of Medicinal Chemistry and Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran. sdemami12@gmail.com.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of Nevada, Reno, Nevada 89557-0216, United States.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of Nevada, Reno, Nevada 89557-0216, United States.
Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of Nevada, Reno, Nevada 89557-0216, United States.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Department of Science, University of Kragujevac, Institute of Information Technologies, Jovana Cvijica bb, 34000 Kragujevac, Serbia.
Faculty of Science, University of Kragujevac, Radoja Domanovića 12, 34000 Kragujevac, Serbia.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Roma, Italy.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Faculty of Physical Chemistry, University of Belgrade, Studenski trg 12-16, 11000 Belgrade, Serbia.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Department of Science, University of Kragujevac, Institute of Information Technologies, Jovana Cvijica bb, 34000 Kragujevac, Serbia.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, PR China; Shandong Provincial Key Laboratory of Chemical Energy Storage and Novel Cell Technology, Liaocheng University, Liaocheng 252059, PR China.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, PR China.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, PR China. Electronic address: lywqp@126.com.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, PR China.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, PR China.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, PR China; Shandong Provincial Key Laboratory of Chemical Energy Storage and Novel Cell Technology, Liaocheng University, Liaocheng 252059, PR China. Electronic address: lidacheng62@163.com.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, PR China.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, PR China.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products, Ningbo University, Ningbo, Zhejiang 315211, China.
Laboratory of Biochemistry and Molecular Biology, School of Marine Sciences, Meishan Campus, Ningbo University, Ningbo, Zhejiang 315832, China.
Key Laboratory of Applied Marine Biotechnology of Ministry of Education, Meishan Campus, Ningbo University, Ningbo, Zhejiang 315832, China.
Publications dans "4-Hydroxycoumarines" :
2 publications dans cette catégorie
Affiliations :
School of Chemistry & Chemical Engineering, Zhoukou Normal University, Zhoukou, Henan 466001, China.
Publications dans "4-Hydroxycoumarines" :
The risk of death from ovarian cancer is highly associated with the clinical stage at diagnosis. Efforts to implement screening for ovarian cancer have been largely unsuccessful, due to the low preval...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy that is increasingly common. Screening for pancreatic cancer is not well established but might increase the chance of detection in e...
We conducted a literature search to summarize current recommendations and to give an overview of patient groups that may benefit from screening. In the general population, screening is not recommended...
There are well-defined populations with distinct genetic alterations with an increased risk for pancreatic cancer. Those may be screened with common diagnostic methods. In addition, new-onset diabetes...
MicroRNAs (miRNAs) are emerging as essential liquid biopsy markers for early cancer detection. Currently, the clinical applications of miRNAs are lagging behind due to their high sequence similarity a...
Ovarian cancer ranks fifth in cancer-related deaths among women. Since ovarian cancer patients are often asymptomatic, most patients are diagnosed only at an advanced stage of disease. This results in...
According to the World Health Organization, cancer is a leading cause of death worldwide, representing almost 10 million deaths in 2020 [...]....
Squamous cell carcinoma forms the vast majority of head and neck malignancies, with advanced disease incurring poor long-term survival. Early detection and prompt specialist referral allows the patien...
Early detection of cancer is considered a cornerstone of preventive medicine and is widely perceived as the gateway to reducing cancer deaths. Based on this assumption, large trials are currently unde...
Cancer is a worldwide pandemic. The burden it imposes grows steadily on a global scale causing emotional, physical, and financial strains on individuals, families, and health care systems. Despite bei...
Over recent decades, synthetic macrocyclic compounds have attracted interest from the scientific community due to their ability to selectively and reversibly form complexes with a huge variety of gues...
Lung cancer remains the deadliest cancer in the world, and lung cancer survival is heavily dependent on tumor stage at the time of detection. Low-dose computed tomography screening can reduce mortalit...
We prospectively recruited 1384 individuals meeting the National Lung Screening Trial demographic eligibility criteria for lung cancer and collected stabilized whole blood to enable the pipetting-free...
We generated diagnostic models and report a median receiver-operating characteristic area under the curve of 0.86 (95% confidence interval [CI]: 0.84-0.86) in the discovery cohort and generalized perf...
These data suggest the potential of a small RNA-based blood test as a viable alternative to low-dose computed tomography screening for early detection of smoking-associated lung cancer....